APMD — Apnimed, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1745648 ·
Last close
$21.09
Market Cap
—
52W High
$35.29
52W Low
$16.12
ADV30
510,477
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 12,080,000 | 10,870,000 | -11,704,000 | 125,935,000 | 195,456,000 | 172,804,000 | 371,637,000 |
| Mar 2026 | 84,814,000 | 82,654,000 | 68,044,000 | 70,373,000 | 342,634,000 | 328,884,000 | 85,044,000 |
| Jun 2025 | 17,110,000 | 15,386,000 | -5,936,000 | -69,474,000 | — | — | — |
| Mar 2025 | 3,131,000 | 1,814,000 | -27,112,000 | -28,646,000 | — | — | — |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-83,747,000
Investing CF
—
Financing CF
$85,468,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$1.87
As of
2026-09-13
Balance + Analyst (yfinance extras)
Retained Earnings
$-203,690,000
Inventory
—
Receivables
$690,000
ST Investments
—
EBIT TTM
$23,292,000
Pretax Income TTM
$164,178,000
Interest Exp TTM
—
Analysts
3
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 38,467,000 | -53,818,000 | -932,000 | 72,873,000 | 445,656,000 | -372,783,000 | -77,832,000 |
| Dec 2024 | 8,012,000 | -114,234,000 | -111,305,000 | 109,223,000 | 357,838,000 | -248,615,000 | -110,209,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.06T | $1183.46 | — |
| JNJ | JOHNSON & JOHNSON | $653.61B | $271.22 | — |
| ABBV | AbbVie Inc. | $467.12B | $264.34 | — |
| MRK | Merck & Co., Inc. | $367.07B | $148.78 | — |
| NVS | NOVARTIS AG | $276.48B | $145.46 | — |
News headlines (Yahoo Finance, 1h cache)
Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update
2026-09-08 20:39 · Yahoo
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2026-09-04 20:01 · Yahoo
BofA makes bullish call on newly public biotech stock
2026-08-29 01:03 · Yahoo
Apnimed shares surge on bullish BofA initiation
2026-08-25 16:12 · Yahoo
Was Moderna Stock's Cancer Vaccine Run Visible In Advance?
2026-09-22 17:39 · Yahoo
Moderna Stock Carries A Market Value Its Revenue Does Not Support
2026-08-26 15:13 · Yahoo
Moderna Stock Had A Readout Waiting In Plain Sight
2026-08-24 19:01 · Yahoo
Moderna's Melanoma Result Landed On A Market Positioned The Other Way
2026-08-20 18:21 · Yahoo
Apnimed (APMD) Joins The NASDAQ Composite Index
2026-08-14 07:12 · Yahoo
Stock Market, IPO Leaders Rally To New Highs. Check This Screen Daily.
2026-08-07 13:52 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.